Opthea Limited is a biopharmaceutical company developing novel therapies to treat eye diseases, including wet age-related macular degeneration and diabetic macular edema.
Ticker code: ASX:OPT
Sector: Healthcare | Industry: Biotechnology | Website: https://opthea.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $738,750,080 | $937,340,224 | 1231250048 | 60.4 | $446,214,539 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| None | $48,443,000 | $246,992,992 | None | None | 0.0 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| None | None | None | None | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | 2004-10-11 | None |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| None | None | None | None | None | None | None |
ASX:OPT Price Chart with Volume and 3EMA
ASX:OPT Short Positions
Click HERE to understand why the above moving averages have been chosen.